Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01145066 · ClinicalTrials.gov registry record · Phase 2
Botanical Oil Supplementation in Diabetic and Metabolic Syndrome Subjects
A Phase 2 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 2
- Development phase
- 80
- Enrollment target
NCT01145066: Completed Phase 2 study, sponsored by Wake Forest University Health Sciences.
NCT01145066 is a Phase 2 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 80 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (40% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01145066, a Phase 2 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 80 participants
- Enrollment target
Study Summary
This study will compare how well a combination of borage and echium oils will reduce inflammation compared to fish oils and placebo oil in subjects that are diabetic or have metabolic syndrome.
Interventions
- DIETARY_SUPPLEMENT fish oil
- DIETARY_SUPPLEMENT corn oil
- DRUG borage/echium oil combination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2009-05 |
| Est. Completion | 2011-03 |
| Phase | Phase 2 |
What the finished NCT01145066 record still lists
NCT01145066 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (40% lower).
The record links to 0 conditions, and to 3 interventions - of which fish oil is the first listed.
NCT01145066 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01145066 about?
NCT01145066 is a clinical study titled "Botanical Oil Supplementation in Diabetic and Metabolic Syndrome Subjects". This study will compare how well a combination of borage and echium oils will reduce inflammation compared to fish oils and placebo oil in subjects that are diabetic or have metabolic syndrome.
What is the current status of trial NCT01145066?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2009-05. Estimated completion is 2011-03.
What interventions are being tested in trial NCT01145066?
The interventions under investigation include: fish oil (DIETARY_SUPPLEMENT), corn oil (DIETARY_SUPPLEMENT), borage/echium oil combination (DRUG).
Who is sponsoring clinical trial NCT01145066?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01145066's enrollment target sits among peer trials
80 842nd of 2000 higher than 1,117 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia